{Reference Type}: Case Reports
{Title}: OCD symptoms in succinic semialdehyde dehydrogenase (SSADH) deficiency: a case report.
{Author}: Phakey S;Rego T;Gaillard F;Panetta J;Evans A;De Jong G;Walterfang M;
{Journal}: BMC Psychiatry
{Volume}: 20
{Issue}: 1
{Year}: 08 2020 5
{Factor}: 4.144
{DOI}: 10.1186/s12888-020-02794-8
{Abstract}: Succinic semialdehyde dehydrogenase (SSADH) deficiency is a rare neurometabolic disorder resulting in a heterogeneous clinical phenotype. Adolescent and adult patients with SSADH deficiency may present with OCD symptoms. There is minimal literature regarding the pathological basis of OCD symptoms and their management amongst SSADH deficiency patients.<BR>A 26-year-old woman with SSADH deficiency experienced obsessional slowness and hesitancy in her activities of daily living, with motor rituals and stereotypies of her hands and face. Neuroimaging revealed T2 hyperintensities of the globi pallidi bilaterally. Commencement of the serotonergic escitalopram moderately improved her OCD symptoms. The addition of the dopaminergic pramipexole hydrochloride yielded further improvement, following unsuccessful trial of other adjuncts: risperidone, methylphenidate and mirtazapine.<BR>Pallidal pathology may explain the manifestation of OCD symptoms amongst individuals with SSADH deficiency. Serotonergic and concomitant dopaminergic therapy may be a viable treatment regimen for SSADH deficiency patients presenting with OCD symptoms.